Table Of Contents
1 Introduction 21
1.1 Objectives Of The Study 21
1.2 Market Definition 21
1.3 Overview Of Middle East And Africa Antimicrobial Susceptibility Testing Market 21
1.4 Currency And Pricing 22
1.5 Limitation 22
1.6 Markets Covered 23
2 Market Segmentation 25
2.1 Markets Covered 25
2.2 Geographic Scope 26
2.3 Years Considered For The Study 27
2.4 Currency And Pricing 27
2.5 Research Methodology 28
2.6 Primary Interviews With Key Opinion Leaders 31
2.7 The Category Vs Time Grid 32
2.8 DBMR Market Challenge Matrix 33
2.9 Secondary Sources 34
2.10 Assumptions 34
3 Market Overview 35
3.1 Drivers 37
3.1.1 Increase In Number Of Infectious Disease 37
3.1.2 Technological Advancements In Antimicrobial Susceptibility Methods 38
3.1.3 Emergence Of Multidrug Resistance Due To Multiple Drug Use 39
3.1.4 Increased Funding, Research Grants, And Public-Private Investments 40
3.2 Restraints 41
3.2.1 High Cost Of Automated Antimicrobial Susceptibility Testing Systems 41
3.3 Opportunities 42
3.3.1 Emerging Markets To Offer Lucrative Opportunities 42
3.3.2 Increase Awareness To Detect And Control Antimicrobial Resistance 43
3.4 Challenges 44
3.4.1 Lack Of Coordination Between Regulatory Bodies, Clinical Laboratories, And Ast Manufacturers 44
4 Executive Summary 45
5 Premium Insights 47
6 Middle East And Africa Antimicrobial Susceptibility Testing Market, By Product 49
6.1 Overview 50
6.2 Manual 52
6.2.1 Susceptibility Testing Disks 53
6.2.2 Mic Strips 54
6.2.3 Susceptibility Plates 54
6.2.4 Antimicrobial Susceptibility Testing Culture Media 55
6.2.5 Consumables 55
6.3 Automated 56
6.3.1 Susceptibility Plates 57
6.3.2 Automated Instruments 58
6.3.3 Susceptibility Plate Ancillaries 58
7 Middle East And Africa Antimicrobial Susceptibility Testing Market, By Methods 59
7.1 Overview 60
7.2 Dilution Methods 61
7.3 Disk Diffusion Method 62
7.4 E- Test 63
7.5 Genotypic Methods 65
7.6 Automated Systems 66
8 Middle East And Africa Antimicrobial Susceptibility Testing Market, By Application 67
8.1 Overview 68
8.2 Clinical Diagnostics 69
8.3 Drug Discovery And Development 70
8.4 Epidemiology 71
8.5 Others 73
9 Middle East And Africa Antimicrobial Susceptibility Testing Market, By End User 74
9.1 Overview 75
9.2 Hospitals 77
9.3 Pharmaceutical And Biotechnology Companies 79
9.4 Diagnostic Laboratories 80
9.5 Research And Academic Institutes 81
9.6 Contract Research Organizations 82
10 Middle East And Africa Antimicrobial Susceptibility Testing Market, By Geography 83
10.1 Middle East & Africa 83
10.1.1 South Africa 90
10.1.1 Egypt 90
10.1.1 Saudi Arabia 90
10.1.1 United Arab Emirates 90
10.1.1 Israel 90
10.1.2 Rest Of Middle East & Africa 94
11 Middle East And Africa Antimicrobial Susceptibility Testing Market,
Company Landscape 95
11.1 Company Share Analysis; Middle East And Africa 95
12 Company Profiles 96
12.1 Biom?rieux Sa Company 96
12.1.1 Overview 96
12.1.2 Revenue Analysis 96
12.1.3 Company Share Analysis 97
12.1.4 Product Portfolio 97
12.1.5 Recent Developments 98
12.2 Thermo Fisher Scientific Inc. 100
12.2.1 Company Overview 100
12.2.2 Revenue Analysis 100
12.2.3 Company Share Analysis 101
12.2.4 Product Portfolio 101
12.2.5 Recent Developments 104
12.3 BD 105
12.3.1 Company Overview 105
12.3.2 Revenue Analysis 105
12.3.3 Company Share Analysis 106
12.3.4 Product Portfolio 106
12.3.5 Recent Developments 107
12.4 Accelerate Diagnostics, Inc. 109
12.4.1 Company Overview 109
12.4.2 Revenue Analysis 109
12.4.3 Product Portfolio 109
12.4.4 Recent Developments 110
?
12.5 Alifax Holding S.P.A. 111
12.5.1 Company Overview 111
12.5.2 Geographic Presence 111
12.5.3 Product Portfolio 112
12.5.4 Recent Developments 112
12.6 Bio-Rad Laboratories Inc. 113
12.6.1 Company Overview 113
12.6.2 Revenue Analysis 113
12.6.3 Product Portfolio 114
12.6.4 Recent Developments 114
12.7 Bioanalyse Tibbi Malz. San. Ve Tic. Ltd. Sti. 115
12.7.1 Company Overview 115
12.7.2 Product Portfolio 115
12.7.3 Recent Developments 115
12.8 Conda 116
12.8.1 Company Overview 116
12.8.2 Geographic Presence 116
12.8.3 Product Portfolio 117
12.8.4 Recent Developments 118
12.9 Creative Diagnostics 119
12.9.1 Company Overview 119
12.9.2 Geographic Presence 119
12.9.3 Product Portfolio 120
12.9.4 Recent Developments 120
12.10 Genefluidics Inc.121
12.10.1 Company Overview 121
12.10.2 Product Portfolio 121
12.10.3 Recent Developments 121
12.11 Himedia Laboratories 122
12.11.1 Company Overview 122
12.11.2 Geographic al Presence 122
12.11.3 Product Portfolio 123
12.11.4 Recent Developments 124
12.12 Liofilchem Srl. 125
12.12.1 Company Overview 125
12.12.2 Product Portfolio 125
12.12.3 Recent Developments 126
12.13 Merck Millipore 127
12.13.1 Company Overview 127
12.13.2 Geographic Presence 127
12.13.3 Product Portfolio 128
12.13.4 Recent Developments 128
12.14 Zhuhai Dl Biotech. Co., Ltd 129
12.14.1 Company Overview 129
12.14.2 Product Portfolio 129
12.14.3 Recent Developments 129
13 Related Reports 130